Skip navigation.
 

Graduate Programs

There are three fields of graduate research within the Department of Pharmaceutical Sciences that are currently accepting students: Pharmaceutical Sciences, Molecular Toxicology, and Pharmaceutical Outcomes Research.

The Pharmaceutical Sciences Graduate Program is committed to the application of Pharmaceutics and Medicinal Chemistry to solving problems arising in the field of Pharmaceutical Biotechnology. As such, the program focuses on the formulation, synthesis, manufacture, development, stability, biophysical analysis, characterization, delivery, and biodistribution of biopharmaceutical agents and vaccines. Given the analytical aspects implicit in many of these areas, the research tends to be quantitative and mechanistic in nature, with an emphasis on macromolecular systems (e.g., proteins, nucleic acids, viruses, polymers).

While there is considerable overlap between the two programs, the Molecular Toxicology Graduate Program focuses on the molecular mechanisms underlying the toxic effects of therapeutic agents, industrial chemicals and environmental toxins. An integral component of this program is investigation and characterization of the genetic components that underlie an organism's or tissue's resistance or susceptibility to toxic agents.

A third field of graduate studies is available through the Pharmaceutical Outcomes Research (POR) area of emphasis within the Pharmaceutical Sciences Ph.D. Program. This graduate curriculum is designed to provide competent and highly skilled researchers for the evaluation of health care interventions and their economic, clinical, and humanistic outcomes. Areas of focus available to students undertaking this course of study include pharmacoeconomics, pharmacoepidemiology, health services research, and drug policy.

 

Last updated: 12/20/07